A novel blood based surveillance test using artificial intelligence and next-generation sequencing identified relapse a median of 41 days before clinical detection in patients with AML or MDS ...
CareDx, Inc. ? The Transplant Companytm, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high?value healthcare solutions ...
An fresh look at trial results that propelled the only FDA approval of a chimeric antigen receptor (CAR) T-cell therapy for mantle cell lymphoma (MCL) shows prior treatment with ibrutinib, a ...
Mitochondria possess their own mRNA translation system, mediated by specialized mitoribosomes. Dysregulation of mitochondrial translation disrupts metabolic homeostasis and is linked to various ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results